These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

660 related items for PubMed ID: 7569976

  • 1. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis.
    Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M.
    Science; 1995 Oct 13; 270(5234):286-90. PubMed ID: 7569976
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids.
    Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS.
    Science; 1995 Oct 13; 270(5234):283-6. PubMed ID: 7569975
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. IL-13 suppresses TNF-induced activation of nuclear factor-kappa B, activation protein-1, and apoptosis.
    Manna SK, Aggarwal BB.
    J Immunol; 1998 Sep 15; 161(6):2863-72. PubMed ID: 9743347
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-kappa B, NF-AT, and early growth factors 2/3.
    Delgado M, Ganea D.
    J Immunol; 2001 Jan 15; 166(2):1028-40. PubMed ID: 11145682
    [Abstract] [Full Text] [Related]

  • 8. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation.
    Manna SK, Mukhopadhyay A, Aggarwal BB.
    J Immunol; 2000 Jun 15; 164(12):6509-19. PubMed ID: 10843709
    [Abstract] [Full Text] [Related]

  • 9. Autoregulation of the NF-kappa B transactivator RelA (p65) by multiple cytoplasmic inhibitors containing ankyrin motifs.
    Sun SC, Ganchi PA, Béraud C, Ballard DW, Greene WC.
    Proc Natl Acad Sci U S A; 1994 Feb 15; 91(4):1346-50. PubMed ID: 8108414
    [Abstract] [Full Text] [Related]

  • 10. Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-kappa B.
    Kleinert H, Euchenhofer C, Ihrig-Biedert I, Förstermann U.
    Mol Pharmacol; 1996 Jan 15; 49(1):15-21. PubMed ID: 8569701
    [Abstract] [Full Text] [Related]

  • 11. Vesnarinone suppresses TNF-induced activation of NF-kappa B, c-Jun kinase, and apoptosis.
    Manna SK, Aggarwal BB.
    J Immunol; 2000 Jun 01; 164(11):5815-25. PubMed ID: 10820260
    [Abstract] [Full Text] [Related]

  • 12. Rocaglamide derivatives are potent inhibitors of NF-kappa B activation in T-cells.
    Baumann B, Bohnenstengel F, Siegmund D, Wajant H, Weber C, Herr I, Debatin KM, Proksch P, Wirth T.
    J Biol Chem; 2002 Nov 22; 277(47):44791-800. PubMed ID: 12237314
    [Abstract] [Full Text] [Related]

  • 13. Glucocorticoid-mediated suppression of cytokine-induced matrix metalloproteinase-9 expression in rat mesangial cells: involvement of nuclear factor-kappaB and Ets transcription factors.
    Eberhardt W, Schulze M, Engels C, Klasmeier E, Pfeilschifter J.
    Mol Endocrinol; 2002 Aug 22; 16(8):1752-66. PubMed ID: 12145332
    [Abstract] [Full Text] [Related]

  • 14. Dissociated glucocorticoids with anti-inflammatory potential repress interleukin-6 gene expression by a nuclear factor-kappaB-dependent mechanism.
    Vanden Berghe W, Francesconi E, De Bosscher K, Resche-Rigon M, Haegeman G.
    Mol Pharmacol; 1999 Oct 22; 56(4):797-806. PubMed ID: 10496964
    [Abstract] [Full Text] [Related]

  • 15. Transformation nonresponsive cells owe their resistance to lack of p65/nuclear factor-kappaB activation.
    Hsu TC, Nair R, Tulsian P, Camalier CE, Hegamyer GA, Young MR, Colburn NH.
    Cancer Res; 2001 May 15; 61(10):4160-8. PubMed ID: 11358840
    [Abstract] [Full Text] [Related]

  • 16. Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis.
    Manna SK, Mukhopadhyay A, Van NT, Aggarwal BB.
    J Immunol; 1999 Dec 15; 163(12):6800-9. PubMed ID: 10586080
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of RelA in transgenic mouse thymocytes: specific increase in levels of the inhibitor protein I kappa B alpha.
    Perez P, Lira SA, Bravo R.
    Mol Cell Biol; 1995 Jul 15; 15(7):3523-30. PubMed ID: 7791759
    [Abstract] [Full Text] [Related]

  • 18. Cupric ion blocks NF kappa B activation through inhibiting the signal-induced phosphorylation of I kappa B alpha.
    Satake H, Suzuki K, Aoki T, Otsuka M, Sugiura Y, Yamamoto T, Inoue J.
    Biochem Biophys Res Commun; 1995 Nov 13; 216(2):568-73. PubMed ID: 7488149
    [Abstract] [Full Text] [Related]

  • 19. Glucocorticoid-mediated repression of NFkappaB activity in endothelial cells does not involve induction of IkappaBalpha synthesis.
    Brostjan C, Anrather J, Csizmadia V, Stroka D, Soares M, Bach FH, Winkler H.
    J Biol Chem; 1996 Aug 09; 271(32):19612-6. PubMed ID: 8702657
    [Abstract] [Full Text] [Related]

  • 20. Expression of IkappaBalpha in the nucleus of human peripheral blood T lymphocytes.
    Laín de Lera T, Folgueira L, Martín AG, Dargemont C, Pedraza MA, Bermejo M, Bonay P, Fresno M, Alcami J.
    Oncogene; 1999 Feb 25; 18(8):1581-8. PubMed ID: 10102628
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.